Back to Research
Research · Stock Research

Oracle — $ORCL

The Street sees $210+. The cash flow says earn it.

Research note · July 11, 2026 · For risk-tolerant investors Risk-tolerant investors only
Spot: $141.50Mkt cap: ~$405BBeta (3y): ~2.2Rating: BBB- (S&P)RPO backlog: $638B (+363%)52-wk path: ~$251 → $140

▶ Watch the full video breakdown — every table, the chart, and both flow prints in under 7 minutes

YouTube · OptionFlowTracker

The thesis

Oracle is no longer a sleepy mature software company. It has become a hybrid: a sticky, recurring software platform (more than 70% of revenue recurring or renewable) bolted to one of the most aggressive AI-infrastructure buildouts in the market. Remaining performance obligations stand at $638B, up 363% — roughly 9.5× annual revenue already under contract. That is real demand, not narrative. But the stock has been punished — a slide from roughly $251 to $140 — because the market has started asking what this growth costs. S&P cut the credit rating to BBB-, one notch above junk, and the backlog is concentrated in a handful of AI counterparties: if a customer renegotiates or can't find compute, a chunk of that $638B gets less bankable fast. This is now an execution story, a financing story, and a capital-allocation story all at once.

The growth the market is discounting

Revenue projection ($B)

↑ +89.0%(FY2026–8E)
$67.4BFY2026$90.1BFY2027E$127.4BFY2028E

FY26 actual; FY27–28 estimates per J.P. Morgan · ~37.5% 2-yr CAGR.

EPS projection ($, non-GAAP)

↑ +38.3%(FY2026–8E)
$7.66FY2026$8.05FY2027E$10.59FY2028E

FY26 actual; estimates per J.P. Morgan · ~17.6% 2-yr CAGR.

The gap between the two CAGRs is the Oracle story — revenue rips while FY27 earnings absorb the buildout's bill, then EPS catches up in FY28.

Margins — the part we don't like

MetricFY2026FY2027EFY2028E
Gross margin67.1%61.1%55.1%
EBIT margin42.9%38.2%35.0%
Net margin33.2%26.4%25.0%

Falling margins during a hype cycle are always more dangerous than they look. (Estimates per J.P. Morgan.)

Balance sheet

MetricFY2026FY2027EFY2028E
Long-term debt~$85B~$125B~$165B
Shareholders' equity$20.5B$42.2B$44.9B
Debt / equity4.2×3.0×3.7×
Interest expense (our est.)~$5.8B~$6.5B~$8B+
Working capitalNegativeNegativeNegative

Strong business, stressed balance sheet — BBB- is the agencies saying the margin for error has narrowed. D/E improves in FY27 as the equity raise lands, then deteriorates again as debt outruns retained earnings. Interest expense estimates are ours, off Q4 FY26's $1.44B (+47% YoY) run-rate and rising debt.

Cash flow

MetricFY2026FY2027EFY2028E
Operating cash flow$25.2B$29.9B$39.0B
Capex (≈ total investing CF)($55.7B)($92.5B)($96.0B)
Free cash flow (FCFF)($29.6B)($58.1B)($52.4B)

CFO minus capex — the FCF walk. Investing cash flow is almost entirely capex during the buildout; the single biggest issue with the bull case is contracted future revenue with zero near-term FCF support. (Estimates per J.P. Morgan.)

Our valuation — scenario analysis

ScenarioFY27E EPS (vs consensus)Forward P/EFair valueAnchors to
Bear$7.70 (–4%)15.5×~$119our $120 technical floor
Base$8.05 (in line)20×~$161our $155–160 recovery zone
Bull$8.45 (+5%)26×~$220inside the Street's $210–245

Skew at $141.50: roughly $22 of modeled downside vs $20 base / $79 bull upside.

Model risk

This framework is only as good as its two inputs, and both carry unusual uncertainty. The EPS anchor: our drift band may be too kind — consensus leans on backlog conversion happening on schedule; if a major AI counterparty renegotiates or defers, FY27 EPS doesn't miss by 4%, it misses by far more, and the bear floor moves below $119 with it. Non-GAAP earnings also flatter the picture while free cash flow runs deeply negative: when earnings and cash diverge this widely, the multiple the market will pay becomes less predictable, not more. And the multiple itself: every 1× of P/E is worth about $8 on the stock, so the honest range around any scenario is wide. These scenarios are brackets, not probabilities — treat the table as a map of the debate, not a prediction of the destination.

Where the Street sits

FirmDateRatingTargetBasis
J.P. MorganJun 10Overweight$210 (Dec-26)~24× EV/CY27E GAAP op income
Evercore ISIJul 9Outperform$245Deeply oversold at 17-year support
Value LineMay 1$124–$304 (mid $214)2029–31 projection $350–$525
ConsensusBuy$240–260Nobody disputes the demand

The debate is entirely about what Oracle pays to capture it. Analyst targets attributed as publicly reported.

Technical read — the level map

LevelMeaning
$195–200Where the chart broke
$165–170Upside room into end of July
$155–160First recovery zone if support holds
$135–140Line in the sand — weekly close only; spikes don't count
$120In play if the zone is lost

Potential double/triple bottom at 17-year support, below all major moving averages — we're watching for a false breakdown below $140 that scares out weak hands, then reverses.

Beta — the stock changed character

WindowBeta
5-year (monthly)1.72
3-year2.26
2-year2.84

The AI pivot didn't just change the business — it changed the stock, from mature software (~1.7) to a leveraged AI trade (~2.8). R² of 0.35 means most of the movement is company-specific. OptionFlowTracker calculation, monthly total returns vs the S&P 500.

Signal Update · July 9–10, 2026

The tape is leaning bullish at the lows.

Strong story, stressed engine

Fundamental

$638B backlog vs deeply negative near-term FCF and BBB- credit.

Broken, at the line

Technical

Below all major moving averages, testing 17-year support at $135–140.

Bullish

Options Flow

Ask-side, opening call blocks on back-to-back sessions right at support.

MetricJul 9 PrintJul 10 Print
Contract$143C · 07/31$140C · 07/24
Premium$2.39M + $1.54M follow-on$1.86M
Size / Day volume2,547 / 2,5492,570 · opening print
FillBlock · At AskBlock · At Ask
Confirmed the next morning✅ Verified✅ Verified

On July 9, clustered ask-side buying hit the ORCL July $143 calls — $2.39M in one block, more behind it — and the tape confirmed underneath, pushing $144 → $148 intraday. Confirmed the next morning, before the open, as genuine new positioning. July 10 continued the pattern: a block of July $140 calls at the ask, right at the money, opening well beyond anything already standing in the strike and confirmed the next morning — two for two. Short-dated and near the money — a bet on the move landing soon, not eventually. Ask-side, opening, near-the-money call blocks on back-to-back sessions at 17-year support is precisely the confluence our framework looks for. Research and education, not financial advice.

Insiders

Neutral to mildly negative. No clustered open-market buys signaling conviction, but no discretionary panic-selling to read as bearish either.

Key risks

Backlog concentration in a few AI counterparties — if a customer renegotiates or can't find compute, a chunk of the $638B gets less bankable fast. A funding plan with no room for a demand air-pocket (long-term debt toward ~$165B by FY28E, BBB-, negative free cash flow throughout). Margin compression to ~55% gross. Negative working capital. A rising beta in a market re-rating AI-infrastructure multiples. And a weekly close below $135–140 opens the door to $120.

Bottom line

Great business momentum. Weak current cash economics. Much higher execution risk than software investors are used to. The company is stronger than the stock narrative suggests — but the stock carries more risk than a simple forward P/E makes it look. If Oracle converts this capex wave into durable OCI revenue and normalizes free cash flow, today's ~$141 looks cheap against our base case of ~$161, our bull case of ~$220, and the Street's $210–245. If revenue slips first, the punishment comes fast — there's no cash-flow cushion. Tactical accumulation, not relaxed buy-and-hold — for risk-tolerant investors only. What we're watching: OCI growth durability, capex discipline, backlog conversion, funding needs, and the $135–140 weekly close. Research and education only — not a recommendation; size and manage risk to your own plan.

Catalyst watch

Every Friday's weekly close vs the $135–140 line · Q1 FY27 earnings (September) · AI-counterparty headlines · morning-after confirmation on new flow prints.

Want research like this on the major names, every week? Stock Research Pro is coming — $150/mo at launch; founding members lock in $99/mo forever. Join the waitlist →

Get the next research note free

One option-flow breakdown and a recap of last week — every week, free.

Always free · No credit card · Unsubscribe anytime

Research and education only. Not financial advice, and not a recommendation to buy or sell any security. Company figures reflect OptionFlowTracker's own estimates and analysis; third-party price targets are as publicly reported. Analyst ratings and price targets are attributed to their respective firms as publicly reported and are not our recommendations.